News

Theranos round 2: Trial of Ramesh 'Sunny' Balwani, Elizabeth Holmes' partner, to start next week

Jurys selection set to begin on March 9

The trial of Ramesh "Sunny" Balwani on charges of criminal wire fraud and conspiracy during his time with blood testing company Theranos is set to begin with jury selection on March 9, 2022. Courtesy Getty Images.

The trial of Ramesh "Sunny" Balwani related to the infamous blood testing company Theranos will get underway next week, with jury selection set to begin on March 9.

Balwani, the former business partner and ex-lover of convicted Theranos founder and CEO Elizabeth Holmes, is charged with the same counts of criminal wire fraud and conspiracy against investors, doctors and patients brought against Holmes.

The trial against Holmes went first, beginning in September of last year in San Jose.

In early January, a federal jury returned a verdict convicting Holmes of three counts of wire fraud and one count of conspiracy to commit wire fraud against investors.

The jury acquitted Holmes of four counts related to wire fraud against patients. The jury did not reach a verdict on three additional counts of wire fraud against investors, and the government ended up dismissing those charges.

Help sustain the local news you depend on.

Your contribution matters. Become a member today.

Join

Holmes' sentencing has been put off until Sept. 26. She remains free on bond.

Balwani served in various roles at Theranos, including president, chief operating officer and a board member, from September 2009 through 2016.

The indictment charges that Balwani, along with Holmes, falsely told investors that the company's proprietary Edison machines could perform a full range of clinical blood tests based only on a fingerstick's worth of blood; that the partnership with Walgreens that put Theranos "Wellness Centers" in Walgreens stores beginning in 2013 was rapidly expanding, when in fact the rollout had stalled because of Theranos' poor performance; and that the company was financially stable and would make huge profits in 2014 and 2015.

Balwani is also accused of deceiving investors by conducting misleading demonstrations of the technology at the company's headquarters and by telling them that the company had an ongoing and profitable relationship with the military.

Like Holmes, Balwani is charged with deceiving patients by mispresenting the blood-testing technology as fast, accurate and cheap, even while knowing that the testing was not capable of producing reliable results.

Stay informed

Get daily headlines sent straight to your inbox in our Express newsletter.

Stay informed

Get daily headlines sent straight to your inbox in our Express newsletter.

Given the length of the Holmes trial, U.S. District Judge Edward Davila and the lawyers took steps in pre-trial proceedings on Tuesday to anticipate issues that came up before. Six alternate jurors, in addition to the 12 that will initially sit on the jury, will be selected — one more than in the Holmes case.

The Holmes jury lost three jurors in rapid succession near the beginning of the trial, raising the risk that a mistrial would have to be declared before the case could get to the jury.

This time around, the trial will also start out with slightly longer hours — 9 a.m. to 3 p.m. on Tuesdays, Wednesdays and Fridays — with the idea that the jury may be asked to come in on some Mondays and Thursdays as well.

The Holmes trial started out with the same three-day schedule but allowed jurors to go home at 2 p.m. After a number of delays caused by broken water mains, malfunctioning technology, holidays and lengthy witness examinations, the court extended the hours to as late as 4 p.m., with the jury sometimes asked to come in four or five days a week.

The Balwani defense is also trying to change substantive aspects of the trial by fighting evidence that came in against Holmes, including testimony and exhibits showing that Theranos also conducted blood tests on commercially available analyzers rather than on its own devices.

Prosecutors in the Holmes case frequently brought out this evidence as another key fact that Holmes did not disclose to investors or patients.

In a lengthy written order issued earlier this week, Davila denied Balwani's motion to exclude this evidence, ruling that the indictment "puts Balwani on notice that the scheme to defraud patients includes Theranos' use of unmodified conventional analyzers."

The judge deferred ruling on a defense request to keep out damning evidence that, after problems with Theranos' results came to light, a new lab director ordered that all of the results from tests performed on Theranos devices be voided.

Much of the court's 51-page order simply adopts the evidentiary decisions that were made during the Holmes trial.

Balwani was not present in the courtroom on Tuesday.

The court has reserved Monday and Tuesday of next week to discuss jury questionnaires. Jury selection will begin on Wednesday and continue on Thursday as needed.

Opening statements are scheduled for March 15, with the trial expected to last up to 13 weeks.

Craving a new voice in Peninsula dining?

Sign up for the Peninsula Foodist newsletter.

Sign up now

Follow Palo Alto Online and the Palo Alto Weekly on Twitter @paloaltoweekly, Facebook and on Instagram @paloaltoonline for breaking news, local events, photos, videos and more.

Stay informed on important crime news. Sign up for our FREE daily Express newsletter.

Theranos round 2: Trial of Ramesh 'Sunny' Balwani, Elizabeth Holmes' partner, to start next week

Jurys selection set to begin on March 9

by Susan Nash / Bay City News Foundation /

Uploaded: Tue, Mar 1, 2022, 1:14 pm

The trial of Ramesh "Sunny" Balwani related to the infamous blood testing company Theranos will get underway next week, with jury selection set to begin on March 9.

Balwani, the former business partner and ex-lover of convicted Theranos founder and CEO Elizabeth Holmes, is charged with the same counts of criminal wire fraud and conspiracy against investors, doctors and patients brought against Holmes.

The trial against Holmes went first, beginning in September of last year in San Jose.

In early January, a federal jury returned a verdict convicting Holmes of three counts of wire fraud and one count of conspiracy to commit wire fraud against investors.

The jury acquitted Holmes of four counts related to wire fraud against patients. The jury did not reach a verdict on three additional counts of wire fraud against investors, and the government ended up dismissing those charges.

Holmes' sentencing has been put off until Sept. 26. She remains free on bond.

Balwani served in various roles at Theranos, including president, chief operating officer and a board member, from September 2009 through 2016.

The indictment charges that Balwani, along with Holmes, falsely told investors that the company's proprietary Edison machines could perform a full range of clinical blood tests based only on a fingerstick's worth of blood; that the partnership with Walgreens that put Theranos "Wellness Centers" in Walgreens stores beginning in 2013 was rapidly expanding, when in fact the rollout had stalled because of Theranos' poor performance; and that the company was financially stable and would make huge profits in 2014 and 2015.

Balwani is also accused of deceiving investors by conducting misleading demonstrations of the technology at the company's headquarters and by telling them that the company had an ongoing and profitable relationship with the military.

Like Holmes, Balwani is charged with deceiving patients by mispresenting the blood-testing technology as fast, accurate and cheap, even while knowing that the testing was not capable of producing reliable results.

Given the length of the Holmes trial, U.S. District Judge Edward Davila and the lawyers took steps in pre-trial proceedings on Tuesday to anticipate issues that came up before. Six alternate jurors, in addition to the 12 that will initially sit on the jury, will be selected — one more than in the Holmes case.

The Holmes jury lost three jurors in rapid succession near the beginning of the trial, raising the risk that a mistrial would have to be declared before the case could get to the jury.

This time around, the trial will also start out with slightly longer hours — 9 a.m. to 3 p.m. on Tuesdays, Wednesdays and Fridays — with the idea that the jury may be asked to come in on some Mondays and Thursdays as well.

The Holmes trial started out with the same three-day schedule but allowed jurors to go home at 2 p.m. After a number of delays caused by broken water mains, malfunctioning technology, holidays and lengthy witness examinations, the court extended the hours to as late as 4 p.m., with the jury sometimes asked to come in four or five days a week.

The Balwani defense is also trying to change substantive aspects of the trial by fighting evidence that came in against Holmes, including testimony and exhibits showing that Theranos also conducted blood tests on commercially available analyzers rather than on its own devices.

Prosecutors in the Holmes case frequently brought out this evidence as another key fact that Holmes did not disclose to investors or patients.

In a lengthy written order issued earlier this week, Davila denied Balwani's motion to exclude this evidence, ruling that the indictment "puts Balwani on notice that the scheme to defraud patients includes Theranos' use of unmodified conventional analyzers."

The judge deferred ruling on a defense request to keep out damning evidence that, after problems with Theranos' results came to light, a new lab director ordered that all of the results from tests performed on Theranos devices be voided.

Much of the court's 51-page order simply adopts the evidentiary decisions that were made during the Holmes trial.

Balwani was not present in the courtroom on Tuesday.

The court has reserved Monday and Tuesday of next week to discuss jury questionnaires. Jury selection will begin on Wednesday and continue on Thursday as needed.

Opening statements are scheduled for March 15, with the trial expected to last up to 13 weeks.

Comments

Post a comment

Sorry, but further commenting on this topic has been closed.